Sysmex Inostics GmbH

Inostics is a diagnostics service company providing molecular tools to support individualized cancer patient management and drug development.

The core competency of Inostics is centered around the detection of genetic changes, such as somatic mutations, in blood or tissue samples from patients. The company currently serves the contract research market and the clinical trials services market.

Besides the services, Inostics advances novel technologies and implements them into its services portfolio in order to continuously offer improved diagnostic tools. In summary, Inostics is organized to commercialize advances in cancer research and technology development to the benefit of cancer patients.